Technology
Health
Biotechnology

Histogenics

$0.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0022 (1.10%) Today
-$0.002 (-0.99%) As of 5:54 PM EDT after-hours

Why Robinhood?

You can buy or sell Histogenics and other stocks, options, ETFs, and crypto commission-free!

About HSGX

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. Read More The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

CEO
Employees
49
Headquarters
Waltham, Massachusetts
Founded
2000
Market Cap
18.55M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.84M
High Today
$0.203
Low Today
$0.192
Open Price
$0.1935
Volume
2.18M
52 Week High
$3.00
52 Week Low
$0.08

Collections

Technology
Health
Biotechnology
Advertising and Marketing
Medical
Engineering
Business Services
2014 IPO

HSGX Earnings

-$0.52
-$0.35
-$0.18
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.01 per share
Actual
Expected Aug 12, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.